---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-347196"
form_type: "8-K"
ticker: "SLN"
cik: "0001479615"
company_name: "Silence Therapeutics plc"
filed_at: "2026-08-12T21:23:33+00:00"
generated_at: "2026-08-12T21:26:22.967484+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Silence Therapeutics prices $175M ADS offering at $13.50 per share

## Summary
- Priced 12,962,963 ADSs at $13.50 each; gross proceeds ~$175M before expenses.
- Underwriters' 30-day option for up to 1,944,444 additional ADSs; net proceeds ~$164.0M (~$188.7M if option exercised).
- Closing expected Aug 13, 2026; Jefferies, Morgan Stanley, Cantor and William Blair act as joint book-runners.
- Underwriters purchase price $12.69 per ADS; offering under shelf registration on Form S-3.

## SEC filing metadata
- accession: 0001193125-26-347196
- form_type: 8-K
- ticker: SLN
- cik: 0001479615
- company_name: Silence Therapeutics plc
- filed_at: 2026-08-12T21:23:33+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479615/000119312526347196/0001193125-26-347196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479615/000119312526347196/d168365d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-347196
- JSON: https://secwatch.observer/filing/0001193125-26-347196.json
- Plain text: https://secwatch.observer/filing/0001193125-26-347196.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.